4.7 Article

Huangqin Decoction ameliorates ulcerative colitis by regulating fatty acid metabolism to mediate macrophage polarization via activating FFAR4-AMPK-PPAR? pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Plant Sciences

Effect of Huangqin decoction on regulating intestinal flora in colitis mice characterized as inhibition of the NOD2-dependent pathway

Shaowei Huang et al.

Summary: This study found that Huangqin decoction can regulate the intestinal flora of ulcerative colitis mice, mainly by inhibiting the NOD2-dependent pathway.

PHARMACEUTICAL BIOLOGY (2022)

Article Agriculture, Multidisciplinary

Natural Garlic Organosulfur Compounds Prevent Metabolic Disorder of Lipid and Glucose by Increasing Gut Commensal Bacteroides acidifaciens

Keyu Chen et al.

Summary: This study demonstrates that stable garlic OSCs prevent Western diet-induced metabolic disorder by increasing the abundance of gut Bacteroides acidifaciens and promoting taurine production. Garlic OSCs improve dyslipidemia and fatty liver by enhancing hepatic fatty acid beta-oxidation and inhibiting hepatic gluconeogenesis.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2022)

Article Plant Sciences

Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier

Mu-xia Li et al.

Summary: Huangqin decoction (HQD) exhibits anti-inflammatory effects on DSS-induced colitis in mice by regulating gut microbiota and amino acid metabolism, activating the mTOR signaling pathway, and protecting intestinal mucosal barrier integrity.

PHYTOMEDICINE (2022)

Article Endocrinology & Metabolism

GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice

Zhongyang Lu et al.

Summary: Deficiency of GPR40 does not alleviate high-fat diet-induced NAFLD, but instead increases metabolic abnormalities and hepatic steatosis under a low-fat diet. GPR40 deficiency leads to upregulation of hepatic fatty acid translocase (FAT)/CD36 expression, possibly inhibiting the development of nonalcoholic steatohepatitis by modulating FAT/CD36 expression.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)

Review Pharmacology & Pharmacy

Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease

Yaoyao Du et al.

Summary: The paper highlights the crucial role of macrophage polarization in IBD, discussing the phenotype and function of macrophages as well as potential drug targets for regulation. Existing approaches for regulating macrophage polarization are examined, along with considerations for addressing safety concerns. Evidence suggests that targeting macrophage polarization could be a novel and effective option for treating IBD, but further mechanistic insights are needed to identify precise and effective targets to manipulate macrophages.

EXPERT OPINION ON THERAPEUTIC TARGETS (2021)

Article Chemistry, Multidisciplinary

Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule

Xiao-fang Lan et al.

Summary: This study focused on the herbal component Gancao in LianhuaQingwen capsule, which plays a key role in treating COVID-19. Metabolites of Gancao were found to have an impact on kidney function, highlighting the importance of understanding the therapeutic benefits and safe usage conditions of LianhuaQingwen.

ACTA PHARMACOLOGICA SINICA (2021)

Article Plant Sciences

Effects of Huangqin Decoction on ulcerative colitis by targeting estrogen receptor alpha and ameliorating endothelial dysfunction based on system pharmacology

Min-yao Li et al.

Summary: Huangqin Decoction may act on ulcerative colitis by regulating targets and pathways related to improving the intestinal mucosal barrier and ameliorating endothelial dysfunction. ERS1 may be a new target to explore the mechanisms of UC.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Review Biotechnology & Applied Microbiology

The potential of Akkermansia muciniphila in inflammatory bowel disease

Ting Zhang et al.

Summary: Akkermansia muciniphila is a promising next-generation probiotic with recognized potential applications in metabolic diseases and tumor immunotherapy. Its safety and therapeutic value in human metabolic diseases have been confirmed in recent clinical trials. Additionally, A. muciniphila shows promise in the treatment of intestinal inflammatory diseases, particularly inflammatory bowel disease (IBD).

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)

Review Physiology

FREE FATTY ACID RECEPTORS IN HEALTH AND DISEASE

Ikuo Kimura et al.

PHYSIOLOGICAL REVIEWS (2020)

Review Gastroenterology & Hepatology

The epidemiology of inflammatory bowel disease: East meets west

Wing Yan Mak et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

Aonghus Lavelle et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Multidisciplinary Sciences

A long noncoding RNA regulates inflammation resolution by mouse macrophages through fatty acid oxidation activation

Yukiteru Nakayama et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biochemistry & Molecular Biology

Adrenic acid induces oxidative stress in hepatocytes

Jing Zhao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Pharmacology & Pharmacy

Gut microbiota, a new frontier to understand traditional Chinese medicines

Wuwen Feng et al.

PHARMACOLOGICAL RESEARCH (2019)

Article Biochemistry & Molecular Biology

Treatment in vitro with PPARα and PPARγ ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice

Federico Penas et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)

Review Pharmacology & Pharmacy

The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy

Giovanni Cammarota et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Article Nutrition & Dietetics

Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?

Kristin A. Verbeke et al.

PROCEEDINGS OF THE NUTRITION SOCIETY (2014)

Review Biochemistry & Molecular Biology

Regulation of energy metabolism by long-chain fatty acids

Manabu T. Nakamura et al.

PROGRESS IN LIPID RESEARCH (2014)

Article Gastroenterology & Hepatology

Inflammatory bowel disease: Pathogenesis

Yi-Zhen Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Plant Sciences

Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy

Shwu-Huey Liu et al.

JOURNAL OF ETHNOPHARMACOLOGY (2012)

Article Biochemistry & Molecular Biology

Alterations in intestinal fatty acid metabolism in inflammatory bowel disease

S Heimerl et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)